Lea Adriana Barlang

Lea Adriana Barlang, née Keller (PhD Student)

Since June 2020 PhD Student, AbbVie Ludwigshafen and LMU Munich
2019 MSc in Toxicology, Technische Universität Kaiserslautern, Germany
2017 Intern, AbbVie Deutschland GmbH & Co.KG, Ludwigshafen, Germany
2017 Bachelor of Science Biology, Albert-Ludwigs Universität-Freiburg im Breisgau, Germany
2016 Semester abroad, University of Manchester, England

Barlang LA, Deimel I, Mohl BP, Blaurock C, Balkema-Buschmann A, Weinbender K, Hess B, Obernolte H, Merkel OM, Popp A:
Distribution and suitability of pulmonary surfactants as a vehicle for topically applied antibodies in healthy and SARS-CoV-2 infected rodent lungs.
Eur J Pharm Sci. 2024 Mar 11;196:106744. doi: 10.1016/j.ejps.2024.106744.

Lea-Adriana Barlang, Kristina Weinbender, Olivia M Merkel, Andreas Popp: SARS-CoV-2 induced changes in the glycosylation pattern in the respiratory tract of Golden Syrian hamsters.
Drug Delivery and Translational Research, 2023, doi: 10.1007/s13346-023-01474-w.

Lea-Adriana Barlang, Björn-Patrick Mohl, Claudia Blaurock, Sophia Harder, Angele Breithaupt, Olivia M Merkel, Anne Balkema-Buschmann, Andreas Popp: SARS-CoV-2 induced changes in the glycosylation pattern in the respiratory tract of Golden Syrian hamsters.
Acta Histochemica, 2023, 125 (7): 152077.

Lea-Adriana Keller, Olivia Merkel*, Andreas Popp: Intranasal drug delivery: opportunities and toxicologic challenges during drug development
Drug Delivery and Translational Research, 2021, doi:10.1007/s13346-020-00891-5